Overall, the findings suggest that maintaining good control of INR levels, as reflected by a higher TTR, is associated with a decreased risk of cognitive impairment and dementia in AF patients receiving warfarin or VKA therapy. This evidence concerns the gene TTR and Cognitive impairment.